Małgorzata Lasota

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, Michal W Sarna, Marta Kaczor-Kamińska, Anna Misterka, Mateusz Szczepaniak, Joanna Dulińska-Litewka, Andrzej Gorecki
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer. International journal of molecular sciences 25 (1) (2023)
Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, Michal W Sarna, Marta Kaczor-Kamińska, Anna Misterka, Mateusz Szczepaniak, Joanna Dulińska-Litewka, Andrzej Gorecki
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer. International journal of molecular sciences 25 (1) (2023)
Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, Michal W Sarna, Marta Kaczor-Kamińska, Anna Misterka, Mateusz Szczepaniak, Joanna Dulińska-Litewka, Andrzej Gorecki
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder Cancer. International journal of molecular sciences 25 (1) (2023)
Jagusiak Anna, Tomasz Gosiewski, Dorota Romaniszyn, Małgorzata Lasota, Anna Wiśniewska, Katarzyna Chłopaś, Barbara Ostrowska, Izabela Kościk, Małgorzata Bulanda
Antibacterial Therapy by Ag + Ions Complexed with Titan Yellow/Congo Red and Albumin during Anticancer Therapy of Urinary Bladder Cancer. International journal of molecular sciences 23 (1) (2021)
Klaudia Skrzypek, Marta Kot, Paweł Konieczny, Artur Nieszporek, Anna Kusienicka, Małgorzata Lasota, Wojciech Bobela, Urszula Jankowska, Sylwia Kędracka-Krok, Marcin Majka
SNAIL Promotes Metastatic Behavior of Rhabdomyosarcoma by Increasing EZRIN and AKT Expression and Regulating MicroRNA Networks. Cancers 12 (7) (2020)